semaglutide recent news Scientists create new Ozempic replacement targeting 30% weight loss A new clinical trial supported

And then were going to talk about some of our game changers

doi: 10.1016/j.gene.2013.12.065

Compared to CJC-1295 DAC (tetra-substituted GHRH analog with Drug Affinity Complex, 6-8 day half-life), Tesamorelin presents a short plasma half-life of approximately 8 minutes via SC route (FDA Egrifta SV label)

GLP-1 weight loss users significantly reduce their unit volume of food purchasing (-8.6%) and more revealingly of alcohol (-14.5%).[18] More recent, less accurate, survey research on GLP-1 weight-loss drug users from September 2023 suggests the following rank order of reported decreased consumption that features a big impact to the QSR and candy industries: Fast Food (77%) Pizza restaurants (74%) Confectionery (72%) Carbonated/sugary drinks (70%) Cookies/baked products (69%) Alcohol (66%)[19] Top foods where users report an increase in consumption: Fruits and vegetables 54% Weight-loss management foods (44%) Poultry and fish (38%)[20] GLP-1 drugs, unlike bariatric surgery, appear to have a strong effect on muting intrinsic desire for compulsive (and impulsive) eating and drinking